# Supernus (SUPN) — News

SUPN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/supn/news

## Recent headlines

- [Supernus Pharmaceuticals, Inc.: BofA global research cuts price objective to $55 from $60](https://www.ainvest.com/news/supernus-pharmaceuticals-bofa-global-research-cuts-price-objective-55-60-2610) — AInvest Wire, Oct 15, 2026
  BofA Global Research has revised its price objective for Supernus Pharmaceuticals, Inc. (SUPN) to $55 from $60, reflecting updated expectations for the company’s performance. The adjustment comes amid ongoing analysis of the company’s strategic direction and market positioning. While the firm…
- [Indivior Pharmaceuticals - Special dividend payment contingent on closing of Supernus merger expected Nov 2, 2026](https://www.ainvest.com/news/indivior-pharmaceuticals-special-dividend-payment-contingent-closing-supernus-merger-expected-nov-2-2026-2609) — AInvest Wire, Sep 17, 2026
  Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) and Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) have announced a definitive agreement to merge in a tax-free all-stock transaction, creating a combined entity named Supernus, Inc. The merger is expected to close in the fourth quarter of 2026, pending…
- [Indivior dividend contingent on merger with Supernus](https://www.ainvest.com/news/indivior-dividend-contingent-merger-supernus-2609) — AInvest Wire, Sep 17, 2026
- [Supernus: deal includes termination fee of up to $174M](https://www.ainvest.com/news/supernus-deal-includes-termination-fee-174m-2608) — AInvest Wire, Aug 3, 2026
- [Indivior Pharmaceuticals Inc: Supernus must pay co termination fee of $101 mln if the merger agreement is terminated under certain circumstances](https://www.ainvest.com/news/indivior-pharmaceuticals-supernus-pay-termination-fee-101-mln-merger-agreement-terminated-circumstances-2608) — AInvest Wire, Aug 3, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).